Simple Summary Pain associated with cancer diagnoses is a serious concern and one of
the most common symptoms reported by cancer patients. The insufficient relief of cancer …

Lung cancer still contributes to nearly one‐quarter cancer‐related deaths in the past
decades, despite the rapid development of targeted therapy and immunotherapy in non …

Background With the increased use of immune checkpoint inhibitors (ICIs) in advanced lung
cancer, adverse events (AEs), particularly immune-related AEs (irAEs), have garnered …

Despite improved methods of diagnosis and the development of different treatments,
mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) …

Studying the cellular geographic distribution in non-small cell lung cancer is essential to
understand the roles of cell populations in this type of tumor. In this study, we characterize …

Lung cancer is a leading cause of cancer-related deaths, and the most common type is lung
adenocarcinoma (LUAD). LUAD is frequently diagnosed in people who never smoked …

BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in
these cases for the first and second line is not clear. An international registry was created for …

Simple Summary Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of
advanced non-small-cell lung cancer (NSCLC) leading to substantial improvement in …

Background Lung cancer is the primary cause of cancer-related deaths in China. This study
analysed the incidence and survival trends of lung cancer from 2011 to 2020 in Fujian …

Gene therapy offers an alternative and promising avenue to lung cancer treatment. Here, we
used dibenzocyclooctyne (DBCO)‐branched primers to construct a PTEN gene nanovector …